Clinical Trial: QT-prolongation in Psychiatric Hospitals

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: QT-prolongation in Psychiatric Hospitals

Brief Summary: Observational study in 6 psychiatric hospitals in Flanders. Patients are included when a QT-prolonging drug is added to a medication profile that already contains a potential QT-prolonging drug. An ECG is taken before the administration of the new drug and a week after starting the new drug to investigate the change in duration of the QTc-interval. Risk factors for developing QT-prolongation and blood concentrations of potassium and creatinine are documented.

Detailed Summary:
Sponsor: Katholieke Universiteit Leuven

Current Primary Outcome: change in QTc-interval (corrected for heart rate) [ Time Frame: before and one week after the start of a QT-prolonging drug ]

Original Primary Outcome: QTc-interval (corrected for heart rate) [ Time Frame: before and one week after the start of a QT-prolonging drug ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Katholieke Universiteit Leuven

Dates:
Date Received: January 21, 2014
Date Started: October 2010
Date Completion:
Last Updated: July 27, 2015
Last Verified: July 2015